Why the study?
Does continuing versus withdrawing long-term beta-blocker therapy affect cardiovascular stability during postoperative bupivacaine intercostal nerve blockade in patients undergoing gall bladder surgery?
Does continuing versus withdrawing long-term beta-blocker therapy affect cardiovascular stability during postoperative bupivacaine intercostal nerve blockade in patients undergoing gall bladder surgery?
Bupivacaine for intercostal nerve blockade does not negatively affect cardiovascular stability in patients on long-term beta-blockers, though caution is warranted in patients with concurrent heart failure due to potential additive cardiodepression.
Answers are grounded in this paper and cite their sources.
Supports intercostal blockade for reducing postoperative arrhythmias in beta-blocked patients; extends RCT evidence on perioperative safety with continued beta-blockade.
Possible cardiovascular side effects of a local anaesthetic in patients on long-term beta-receptor blocking therapy were studied in 26 patients given postoperative intercostal nerve blockades (ICB) with 18-28 ml of plain bupivacaine 0.5% (1.30-1.82 mg kg-1). The patients had a history of hypertension and/or ischaemic heart disease and were scheduled for gall bladder surgery. Thirteen patients were randomized to a gradual preoperative withdrawal of the beta-receptor blockers and the other 13 continued the beta-receptor blockade until surgery. Cardiovascular changes were measured noninvasively and 11 patients were also monitored with pulmonary artery catheters. Blood pressure and heart rate (HR) were stable in all patients although those in whom the beta-receptor blockade was withdrawn had the highest HR and most frequent arrhythmias both before and after ICB. The ICB was associated with a decrease in the overall postoperative arrhythmia incidence, but seemed most efficient (P less than 0.02) concerning the ventricular arrhythmias in the beta-receptor-blocked patients (even including idionodal rhythm). The bupivacaine blood levels did not modify other cardiovascular changes except in one beta-receptor-blocked patient with cardiac failure in whom signs of a slight transient cardiodepression were observed. It is concluded that bupivacaine does not negatively affect cardiovascular stability in long-term beta-receptor-blocked patients. In the presence of cardiac failure, however, an additive cardiodepression may be elicited.
No takes yet. Share an insight, caveat, or question.
Pontén et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: